Kairos Pharma, LTD. (KAPA) — S-1/A Filings

S-1/A Filings (7)

• Kairos Pharma Files S-1/A Amendment for IPO — Aug 16, 2024 Risk: medium
  Kairos Pharma, Ltd. filed an S-1/A amendment on August 16, 2024, for its initial public offering under registration number 333-274805. The company, incorporated
• Kairos Pharma Files S-1/A Amendment for IPO — Jun 4, 2024 Risk: medium
  Kairos Pharma, Ltd. filed an S-1/A amendment on June 3, 2024, for its initial public offering under registration number 333-274805. The company, incorporated in
• Kairos Pharma Files S-1/A Amendment for IPO — May 24, 2024 Risk: medium
  Kairos Pharma, Ltd. filed an S-1/A amendment on May 24, 2024, for its initial public offering under registration number 333-274805. The company, incorporated in
• Kairos Pharma Files S-1/A Amendment for IPO — May 20, 2024 Risk: medium
  Kairos Pharma, Ltd. filed an S-1/A amendment on May 20, 2024, for its initial public offering. The company, incorporated in Delaware, is seeking to register an
• Kairos Pharma, Ltd. Files Amendment 4 to S-1 Registration Statement — May 13, 2024 Risk: low
  Kairos Pharma, LTD. (KAPA) filed a Amended IPO Registration (S-1/A) with the SEC on May 13, 2024. Kairos Pharma, Ltd. filed Amendment No. 4 to its Form S-1 Regi
• Kairos Pharma, LTD. Files Amendment to S-1 Registration Statement — May 1, 2024 Risk: low
  Kairos Pharma, LTD. (KAPA) filed a Amended IPO Registration (S-1/A) with the SEC on May 1, 2024. Kairos Pharma, LTD. filed an S-1/A (Amendment No. 3) with the S
• Kairos Pharma, Ltd. Files Amendment 2 to S-1 Registration Statement — Feb 14, 2024 Risk: low
  Kairos Pharma, LTD. (KAPA) filed a Amended IPO Registration (S-1/A) with the SEC on February 14, 2024. Kairos Pharma, Ltd. filed an S-1/A on February 14, 2024.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX